Expertise in
76
conditions

Dr. David Iberri

Hematology
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 
Offers Telehealth
Expertise in
76
conditions
Stanford University
875 Blake Wilbur Dr, 
Palo Alto, CA 

Overview

David Iberri is a Hematologist in Palo Alto, California. Dr. Iberri is highly rated in 76 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Schnitzler Syndrome, Bone Marrow Aspiration, and Splenectomy.

His clinical research consists of co-authoring 21 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in CA

Hospital Affiliations

Stanford Health Care Tri-Valley
Stanford Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Valley Health
  • HMO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Stanford University
875 Blake Wilbur Dr, Palo Alto, CA 94304
Other Locations
Interventional Radiology In San Jose
2589 Samaritan Dr, San Jose, CA 95124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I Study of Lenalidomide Therapy Prior to Re-induction Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine (MEC) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)
A Phase I Study of Lenalidomide Therapy Prior to Re-induction Chemotherapy With Mitoxantrone, Etoposide, and Cytarabine (MEC) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: October 29, 2018
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
A Phase 2 Study of Decitabine in Combination With Midostaurin (PKC412) for Elderly Patients With Newly Diagnosed FLT3-ITD/TKD Positive Acute Myeloid Leukemia
Enrollment Status: Terminated
Publish Date: September 27, 2018
Intervention Type: Drug
Study Phase: Phase 2
An Open-Label Extension Study of Post-Transplant Maintenance Midostaurin (PKC412) in Elderly Patients (Age ≥ 60 Years) With FLT3-ITD/TKD Mutated AML Who Previously Received Midostaurin and Decitabine as Part of Study HEMAML0022 / CPKC412AUS27T
An Open-Label Extension Study of Post-Transplant Maintenance Midostaurin (PKC412) in Elderly Patients (Age ≥ 60 Years) With FLT3-ITD/TKD Mutated AML Who Previously Received Midostaurin and Decitabine as Part of Study HEMAML0022 / CPKC412AUS27T
Enrollment Status: Withdrawn
Publish Date: May 04, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

21 Total Publications

First, do NOHARM: towards clinically safe large language models.
First, do NOHARM: towards clinically safe large language models.
Journal: ArXiv
Published: January 14, 2026
Similar Doctors
Expertise in
42
conditions
Dr. Jason Gotlib
Hematology
Expertise in
42
conditions
Dr. Jason Gotlib
Hematology

Stanford University

875 Blake Wilbur Dr, 
Palo Alto, CA 
 (0.2 miles away)
650-498-6000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jason Gotlib is a Hematologist in Palo Alto, California. Dr. Gotlib is highly rated in 42 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy.

Expertise in
23
conditions
Dr. Bertil Glader
Hematology
Expertise in
23
conditions
Dr. Bertil Glader
Hematology

Lucile Packard Children's Hospital Stanford

725 Welch Rd, 
Palo Alto, CA 
 (0.2 miles away)
650-497-8953
Languages Spoken:
English
See accepted insurances

Bertil Glader is a Hematologist in Palo Alto, California. Dr. Glader is highly rated in 23 conditions, according to our data. His top areas of expertise are Aase Syndrome, Pyruvate Kinase Deficiency, Pure Red Cell Aplasia, Hemolytic Anemia, and Splenectomy.

Expertise in
37
conditions
Dr. David Miklos
Hematology
Expertise in
37
conditions
Dr. David Miklos
Hematology

Stanford Hospital And Clinics

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-0822
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Miklos is a Hematologist in Stanford, California. Dr. Miklos is highly rated in 37 conditions, according to our data. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. David Iberri

How do I make an appointment with Dr. David Iberri?

You can book an appointment with Dr. David Iberri by calling their office at 650-498-6000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David Iberri a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David Iberri is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David Iberri specialize in?

While Dr. David Iberri is a Hematology, they have specific expertise in Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), and Schnitzler Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. David Iberri participate in research or clinical trials?

Yes. Dr. David Iberri has published 21 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. David Iberri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David Iberri accept my insurance?

Dr. David Iberri accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 650-498-6000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Iberri's expertise for a condition
ConditionClose
    View All 14 Distinguished Conditions
    View All 62 Advanced Conditions
    View All 110 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile